Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment

Diffuse large B-cell lymphoma (DLBCL) is characterized by clinical and molecular heterogeneity; however, this heterogeneity is rarely taken into account by standard-of-care treatment approaches. While the disease was traditionally classified based on transcriptome signatures purporting the tumor cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Danilov, Alexey V, Magagnoli, Massimo, Matasar, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842307/
https://www.ncbi.nlm.nih.gov/pubmed/35305092
http://dx.doi.org/10.1093/oncolo/oyab004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842307/
https://www.ncbi.nlm.nih.gov/pubmed/35305092
http://dx.doi.org/10.1093/oncolo/oyab004

Ejemplares similares